BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38710698)

  • 1. CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling.
    Ma Y; Chen Y; Zhan L; Dong Q; Wang Y; Li X; He L; Zhang J
    Cell Death Discov; 2024 May; 10(1):219. PubMed ID: 38710698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer.
    Kwon CH; Park HJ; Choi JH; Lee JR; Kim HK; Jo HJ; Kim HS; Oh N; Song GA; Park DY
    Oncotarget; 2015 Aug; 6(24):20312-26. PubMed ID: 26015410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
    Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
    J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
    Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
    J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpin peptidase inhibitor clade A member 1-overexpression in gastric cancer promotes tumor progression
    Jiang L; Hu LG
    Oncol Lett; 2020 Dec; 20(6):278. PubMed ID: 33014156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.
    Kwon CH; Park HJ; Lee JR; Kim HK; Jeon TY; Jo HJ; Kim DH; Kim GH; Park DY
    Br J Cancer; 2014 Nov; 111(10):1993-2002. PubMed ID: 25211665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPL21 interacts with LAMP3 to promote colorectal cancer invasion and metastasis by regulating focal adhesion formation.
    Zhu J; Long T; Gao L; Zhong Y; Wang P; Wang X; Li Z; Hu Z
    Cell Mol Biol Lett; 2023 Apr; 28(1):31. PubMed ID: 37062845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant SLC6A14 Expression Promotes Proliferation and Metastasis of Colorectal Cancer via Enhancing the JAK2/STAT3 Pathway.
    Mao H; Sheng J; Jia J; Wang C; Zhang S; Li H; He F
    Onco Targets Ther; 2021; 14():379-392. PubMed ID: 33469314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in Colorectal Cancer.
    Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
    Liu W; Geng C; Li X; Li Y; Song S; Wang C
    Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSAT1 mediated EMT of colorectal cancer cells by regulating Pl3K/AKT signaling pathway.
    Wang M; Zhang H; Lu Z; Su W; Tan Y; Wang J; Jia X
    J Cancer; 2024; 15(10):3183-3198. PubMed ID: 38706897
    [No Abstract]   [Full Text] [Related]  

  • 13. Endoplasmic reticulum-resident protein Sec62 drives colorectal cancer metastasis via MAPK/ATF2/UCA1 axis.
    Jin Y; Han Y; Yang S; Cao J; Jiang M; Liang J
    Cell Prolif; 2022 Dec; 55(12):e13253. PubMed ID: 36200182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.
    Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J
    Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
    Guo X; Li Y; Chen X; Sun B; Guo X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT2-induced linc02231 promotes tumorigenesis and angiogenesis through modulation of hnRNPA1/ANGPTL4 in colorectal cancer.
    Xu S; Fang Y; Chang L; Bian Y; Wang Y; Ding J; Wang Y; Zhang Y; Pu J; Wang K
    J Gene Med; 2023 Aug; 25(8):e3506. PubMed ID: 36994700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1.
    Li K; Zhang J; Zhang M; Wu Y; Lu X; Zhu Y
    World J Surg Oncol; 2021 Feb; 19(1):54. PubMed ID: 33608020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.